food propellant - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	food propellant	go back to main search page
Accession:	CHEBI:78017	browse the term
Definition:	A propellant that is used to expel foods from an aerosol container.
Synonyms:	related_synonym:	food propellants

show annotations for term's descendants Sort by:
Rat (1577) Mouse (1595) Human (1620) Chinchilla (0) Bonobo (0) Dog (2) Squirrel (0) Pig (9) Green Monkey (0) Naked Mole-rat (0) All
Genes (1595)

(-)-secoisolariciresinol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

nuclear receptor subfamily 1, group I, member 2

increases activity

secoisolariciresinol results in increased activity of NR1I2 protein

NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186

1-nitropropane

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP-binding cassette, sub-family B member 1B

increases expression

1-nitropropane results in increased expression of ABCB1B mRNA

NCBI chr 5:8,848,147...8,916,314
Ensembl chr 5:8,848,147...8,916,315

G

amino carboxymuconate semialdehyde decarboxylase

increases expression

1-nitropropane results in increased expression of ACMSD mRNA

NCBI chr 1:127,657,149...127,695,723
Ensembl chr 1:127,657,150...127,695,715

G

acyl-CoA synthetase long-chain family member 3

decreases expression

1-nitropropane results in decreased expression of ACSL3 mRNA

NCBI chr 1:78,635,600...78,685,462
Ensembl chr 1:78,635,542...78,685,460

G

apoptosis enhancing nuclease

increases expression

1-nitropropane results in increased expression of AEN mRNA

NCBI chr 7:78,545,675...78,560,957
Ensembl chr 7:78,545,602...78,560,957

G

aldehyde dehydrogenase family 1, subfamily A1

increases expression

1-nitropropane results in increased expression of ALDH1A1 mRNA

NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829

G

apolipoprotein A-II

increases expression

1-nitropropane results in increased expression of APOA2 mRNA

NCBI chr 1:171,049,133...171,053,948
Ensembl chr 1:171,052,623...171,053,948

G

apolipoprotein A-IV

decreases expression

1-nitropropane results in decreased expression of APOA4 mRNA

NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757

G

apolipoprotein C-III

increases expression

1-nitropropane results in increased expression of APOC3 mRNA

NCBI chr 9:46,144,348...46,146,934
Ensembl chr 9:46,144,231...46,146,934

G

ATPase, H+ transporting, lysosomal V1 subunit D

increases expression

1-nitropropane results in increased expression of ATP6V1D mRNA

NCBI chr12:78,889,756...78,908,810
Ensembl chr12:78,887,499...78,908,412

G

BCL2-associated X protein

increases expression

1-nitropropane results in increased expression of BAX mRNA

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

BTG anti-proliferation factor 2

decreases expression

1-nitropropane results in decreased expression of BTG2 mRNA

NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858

G

complement component 7

decreases expression

1-nitropropane results in decreased expression of C7 mRNA

NCBI chr15:5,017,232...5,093,230
Ensembl chr15:5,018,244...5,093,222

G

Casitas B-lineage lymphoma c

decreases expression

1-nitropropane results in decreased expression of CBLC mRNA

NCBI chr 7:19,513,643...19,530,734
Ensembl chr 7:19,512,806...19,530,734

G

cyclin G1

increases expression

1-nitropropane results in increased expression of CCNG1 mRNA

NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138

G

CD276 antigen

decreases expression

1-nitropropane results in decreased expression of CD276 mRNA

NCBI chr 9:58,431,581...58,463,437
Ensembl chr 9:58,431,581...58,462,720

G

cyclin dependent kinase inhibitor 1A

decreases expression

1-nitropropane results in decreased expression of CDKN1A mRNA

NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701

G

carboxypeptidase Q

decreases expression

1-nitropropane results in decreased expression of CPQ mRNA

NCBI chr15:33,083,275...33,594,698
Ensembl chr15:33,083,275...33,594,698

G

crystallin, alpha B

decreases expression

1-nitropropane results in decreased expression of CRYAB mRNA

NCBI chr 9:50,657,251...50,667,936
Ensembl chr 9:50,662,625...50,667,936

G

dimethylarginine dimethylaminohydrolase 1

decreases expression

1-nitropropane results in decreased expression of DDAH1 mRNA

NCBI chr 3:145,464,447...145,600,032
Ensembl chr 3:145,464,430...145,600,032

G

epithelial cell adhesion molecule

decreases expression

1-nitropropane results in decreased expression of EPCAM mRNA

NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557

G

epoxide hydrolase 1, microsomal

decreases expression

1-nitropropane results in decreased expression of EPHX1 mRNA

NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469

G

Fas cell surface death receptor

increases expression

1-nitropropane results in increased expression of FAS mRNA

NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172

G

fragile histidine triad gene

increases expression

1-nitropropane results in increased expression of FHIT mRNA

NCBI chr14:11,307,718...12,919,681
Ensembl chr14:11,307,738...12,919,681

G

glutamate receptor, ionotropic, AMPA3 (alpha 3)

decreases expression

1-nitropropane results in decreased expression of GRIA3 mRNA

NCBI chr X:40,489,351...40,767,478
Ensembl chr X:40,489,731...40,767,478

G

glutathione S-transferase, mu 1

decreases expression

1-nitropropane results in decreased expression of GSTM1 mRNA

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

hydroxysteroid (17-beta) dehydrogenase 6

increases expression

1-nitropropane results in increased expression of HSD17B6 mRNA

NCBI chr10:127,826,800...127,843,517
Ensembl chr10:127,826,805...127,843,480

G

interleukin 2 receptor, alpha chain

decreases expression

1-nitropropane results in decreased expression of IL2RA mRNA

NCBI chr 2:11,647,603...11,698,005
Ensembl chr 2:11,647,618...11,698,004

G

O-6-methylguanine-DNA methyltransferase

increases expression

1-nitropropane results in increased expression of MGMT mRNA

NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995

G

nuclear protein transcription regulator 1

increases expression

1-nitropropane results in increased expression of NUPR1 mRNA

NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033

G

pleckstrin homology like domain, family A, member 3

decreases expression

1-nitropropane results in decreased expression of PHLDA3 mRNA

NCBI chr 1:135,693,823...135,696,872
Ensembl chr 1:135,693,857...135,696,874

G

Rho-related BTB domain containing 2

increases expression

1-nitropropane results in increased expression of RHOBTB2 mRNA

NCBI chr14:70,022,439...70,062,296
Ensembl chr14:70,022,439...70,043,085

G

serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7

decreases expression

1-nitropropane results in decreased expression of SERPINA7 mRNA

NCBI chr X:137,979,998...137,985,985
Ensembl chr X:137,980,006...137,985,985

G

solute carrier family 16 (monocarboxylic acid transporters), member 10

increases expression

1-nitropropane results in increased expression of SLC16A10 mRNA

NCBI chr10:39,909,528...40,018,262
Ensembl chr10:39,909,528...40,018,254

G

serine peptidase inhibitor, Kazal type 1

increases expression

1-nitropropane results in increased expression of SPINK1 mRNA

NCBI chr18:43,861,134...43,870,302
Ensembl chr18:43,861,147...43,870,622

G

succinyl-CoA glutarate-CoA transferase

decreases expression

1-nitropropane results in decreased expression of SUGCT mRNA

NCBI chr13:17,032,057...17,869,380
Ensembl chr13:17,032,057...17,870,138

G

sulfatase 2

increases expression

1-nitropropane results in increased expression of SULF2 mRNA

NCBI chr 2:165,915,819...165,997,603
Ensembl chr 2:165,915,009...165,997,583

G

sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1

increases expression

1-nitropropane results in increased expression of SULT2A1 mRNA

NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334

G

zinc finger matrin type 3

decreases expression

1-nitropropane results in decreased expression of ZMAT3 mRNA

NCBI chr 3:32,388,941...32,419,814
Ensembl chr 3:32,388,941...32,420,163

aloxistatin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

calpain 1

multiple interactions

aloxistatin inhibits the reaction [CAPN1 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]

NCBI chr19:6,038,573...6,065,855
Ensembl chr19:6,038,573...6,065,927

G

calpain 7

multiple interactions

aloxistatin inhibits the reaction [CAPN7 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]

NCBI chr14:31,058,582...31,093,944
Ensembl chr14:31,058,595...31,093,943

G

caspase 3

multiple interactions

[aloxistatin co-treated with pepstatin] inhibits the reaction [[vistusertib co-treated with Chloroquine] results in increased activity of CASP3 protein]
[Swainsonine co-treated with aloxistatin] results in increased cleavage of CASP3 protein

PMID:26853465 PMID:33186601

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 9

multiple interactions

aloxistatin inhibits the reaction [syringic acid analog results in increased secretion of CASP9 protein]

NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287

G

cathepsin B

multiple interactions

[aloxistatin co-treated with pepstatin] results in decreased expression of CTSB protein; aloxistatin inhibits the reaction [CTSB protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]

PMID:30910806 PMID:32186374

NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372

G

cathepsin D

multiple interactions

[aloxistatin co-treated with pepstatin] results in decreased expression of CTSD protein

NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775

G

cathepsin L

multiple interactions

aloxistatin inhibits the reaction [CTSL protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]

NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704

G

DEAD box helicase 3, X-linked

multiple interactions

aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of DDX3X protein]

NCBI chr X:13,147,261...13,160,222
Ensembl chr X:13,147,209...13,160,291

G

eukaryotic translation initiation factor 4A1

multiple interactions

aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4A1 protein]

NCBI chr11:69,557,762...69,563,249
Ensembl chr11:69,557,762...69,563,249

G

eukaryotic translation initiation factor 4H

multiple interactions

aloxistatin inhibits the reaction [[quizartinib co-treated with spautin-1] results in increased degradation of EIF4H protein]

NCBI chr 5:134,648,726...134,668,263
Ensembl chr 5:134,648,575...134,668,344

G

glyceraldehyde-3-phosphate dehydrogenase

multiple interactions

aloxistatin inhibits the reaction [syringic acid analog results in increased secretion of GAPDH protein]

NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430

G

lysosomal-associated membrane protein 2

multiple interactions

[aloxistatin co-treated with pepstatin] results in increased expression of LAMP2 protein

NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331

G

microtubule-associated protein 1 light chain 3 beta

multiple interactions
increases lipidation

[aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] promotes the reaction [ABTL0812 results in increased expression of and results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] promotes the reaction [Brefeldin A results in increased expression of and results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] promotes the reaction [N-((1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl)octanamide results in increased expression of and results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] results in decreased degradation of MAP1LC3B protein modified form; aloxistatin promotes the reaction [indatraline results in increased lipidation of MAP1LC3B protein]
aloxistatin results in increased lipidation of MAP1LC3B protein
[aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased degradation of MAP1LC3B protein modified form]; [aloxistatin co-treated with pepstatin] inhibits the reaction [Dronabinol results in increased lipidation of MAP1LC3B protein]; [aloxistatin co-treated with pepstatin] results in increased expression of MAP1LC3B protein

PMID:26483381 PMID:27635674 PMID:32397857 PMID:33124469

NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499

G

sequestosome 1

multiple interactions
increases expression

[aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; aloxistatin promotes the reaction [indatraline results in increased expression of SQSTM1 protein]; aloxistatin promotes the reaction [Sertraline results in increased expression of SQSTM1 protein]
aloxistatin results in increased expression of SQSTM1 protein
[aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; [Dronabinol co-treated with aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein; [HU 211 co-treated with aloxistatin co-treated with pepstatin] results in increased expression of SQSTM1 protein

PMID:26483381 PMID:32186374 PMID:32773031 PMID:33124469

NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654

busulfan

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adrenergic receptor, beta 2

decreases response to substance

ADRB2 protein results in decreased susceptibility to Busulfan

NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030

G

aryl-hydrocarbon receptor

increases expression

Busulfan results in increased expression of AHR mRNA

NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037

G

acidic nuclear phosphoprotein 32 family member B

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of ANP32B protein

NCBI chr 4:46,450,926...46,472,657
Ensembl chr 4:46,450,902...46,472,657

G

apurinic/apyrimidinic endonuclease 1

increases response to substance

APEX1 protein mutant form results in increased susceptibility to Busulfan

NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596

G

androgen receptor

multiple interactions

Busulfan inhibits the reaction [Metribolone results in increased activity of AR protein]

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

Rho GDP dissociation inhibitor alpha

multiple interactions
affects response to substance

ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein]
ARHGDIA mRNA affects the susceptibility to Busulfan

NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450

G

activating transcription factor 4

multiple interactions
increases expression

4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of ATF4 protein]
Busulfan results in increased expression of ATF4 mRNA

PMID:35533795 PMID:35641671

NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742

G

ataxia telangiectasia mutated

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of ATM protein

NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040

G

beclin 1, autophagy related

increases expression
multiple interactions

Busulfan results in increased expression of BECN1 protein
3-methyladenine inhibits the reaction [Busulfan results in increased expression of BECN1 protein]

NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112

G

bone morphogenetic protein 4

decreases expression

Busulfan results in decreased expression of BMP4 mRNA

NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126

G

caspase 3

multiple interactions
increases activity

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP3 protein; [decitabine co-treated with Busulfan] results in increased activity of CASP3 protein; ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein]

PMID:17264767 PMID:18339423 PMID:19732952 PMID:20933509

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 8

increases activity
multiple interactions

Busulfan results in increased activity of CASP8 protein
[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein]

PMID:18339423 PMID:19732952

NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662

G

caspase 9

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein]

PMID:19732952 PMID:20933509

NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287

G

catalase

decreases expression

Busulfan results in decreased expression of CAT protein

NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505

G

cell division cycle 25B

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CDC25B protein

NCBI chr 2:131,028,356...131,040,431
Ensembl chr 2:131,028,869...131,040,417

G

cyclin dependent kinase 2

decreases expression

Busulfan results in decreased expression of CDK2 mRNA

NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900

G

cyclin dependent kinase 4

decreases expression

Busulfan results in decreased expression of CDK4 mRNA

NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789

G

cyclin dependent kinase inhibitor 1A

increases expression
multiple interactions

Busulfan results in increased expression of CDKN1A protein
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of CDKN1A protein

PMID:16882877 PMID:20933509

NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701

G

cyclin dependent kinase inhibitor 2A

increases expression

Busulfan results in increased expression of CDKN2A mRNA

NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890

G

checkpoint kinase 1

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK1 protein

NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361

G

checkpoint kinase 2

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK2 protein

NCBI chr 5:110,987,668...111,022,006
Ensembl chr 5:110,987,845...111,022,011

G

claudin 11

multiple interactions
decreases expression

4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of CLDN11 protein]
Busulfan results in decreased expression of CLDN11 mRNA; Busulfan results in decreased expression of CLDN11 protein

NCBI chr 3:31,204,069...31,218,475
Ensembl chr 3:31,204,069...31,218,473

G

collagen, type I, alpha 1

increases expression

Busulfan results in increased expression of COL1A1 mRNA

NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868

G

collagen, type III, alpha 1

increases expression

Busulfan results in increased expression of COL3A1 mRNA

NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866

G

collagen, type IV, alpha 1

affects expression

Busulfan affects the expression of COL4A1 mRNA

NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826

G

cytochrome P450, family 1, subfamily a, polypeptide 1

decreases activity

Busulfan results in decreased activity of CYP1A1 protein

NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107

G

cytochrome P450, family 2, subfamily c, polypeptide 65

multiple interactions

[GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide]

NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388

G

DNA-damage inducible transcript 3

increases expression
multiple interactions

Busulfan results in increased expression of DDIT3 protein
4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of DDIT3 protein]

NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157

G

eukaryotic translation initiation factor 2 alpha kinase 3

multiple interactions
increases phosphorylation

4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2AK3 protein]

NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229

G

eukaryotic translation initiation factor 2, subunit 1 alpha

multiple interactions
increases phosphorylation

4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2S1 protein]

NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784

G

Fas ligand

decreases expression

Busulfan results in decreased expression of FASL mRNA

NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064

G

fibroblast growth factor 8

decreases expression

Busulfan results in decreased expression of FGF8 mRNA

NCBI chr19:45,724,930...45,731,380
Ensembl chr19:45,725,237...45,731,354

G

follicle stimulating hormone beta

decreases expression

Busulfan results in decreased expression of FSHB protein

NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001

G

ferritin heavy polypeptide 1

decreases expression
multiple interactions

Busulfan results in decreased expression of FTH1 protein
3-methyladenine inhibits the reaction [Busulfan results in decreased expression of FTH1 protein]

NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462

G

glial cell line derived neurotrophic factor

affects expression
increases expression

Busulfan affects the expression of GDNF mRNA
Busulfan results in increased expression of GDNF mRNA

PMID:20684317 PMID:22082982 PMID:26524245

NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056

G

gap junction protein, alpha 1

multiple interactions
decreases expression

4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of GJA1 protein]
Busulfan results in decreased expression of GJA1 mRNA; Busulfan results in decreased expression of GJA1 protein

NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609

G

glutathione peroxidase 4

multiple interactions
decreases expression

3-methyladenine inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; Busulfan results in decreased expression of and results in decreased activity of GPX4 protein; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of GPX4 mRNA]; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]
Busulfan results in decreased expression of GPX4 mRNA; Busulfan results in decreased expression of GPX4 protein

PMID:32416107 PMID:38220133

NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273

G

glutathione S-transferase, mu 1

affects metabolic processing
affects abundance
affects response to substance
multiple interactions

GSTM1 protein affects the metabolism of Busulfan
GSTM1 gene polymorphism affects the abundance of Busulfan
GSTM1 gene polymorphism affects the susceptibility to Busulfan
[GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan; [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide]

PMID:8886613 PMID:15142875 PMID:19584821 PMID:20672371 PMID:21215809 More...

NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289

G

glutathione S-transferase, pi 1

affects abundance
affects metabolic processing

GSTP1 gene polymorphism affects the abundance of Busulfan
GSTP1 protein affects the metabolism of Busulfan

PMID:8886613 PMID:20672371

NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985

G

glutathione S-transferase, theta 1

multiple interactions

[GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan

NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418

G

H2A.X variant histone

increases phosphorylation
multiple interactions

Busulfan results in increased phosphorylation of H2AX protein
[Clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of H2AX protein

PMID:18339423 PMID:20933509

NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374

G

hypoxia inducible factor 1, alpha subunit

increases expression

Busulfan results in increased expression of HIF1A mRNA

NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304

G

heat shock protein 5

increases expression
multiple interactions

Busulfan results in increased expression of HSPA5 protein
4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of HSPA5 protein]

NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559

G

inhibin beta-A

multiple interactions
increases expression

bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA mRNA]; bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA protein]
Busulfan results in increased expression of INHBA mRNA; Busulfan results in increased expression of INHBA protein

PMID:12966370 PMID:22286157

NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206

G

KIT proto-oncogene receptor tyrosine kinase

decreases expression

Busulfan results in decreased expression of KIT mRNA

NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382

G

laminin, alpha 1

affects expression

Busulfan affects the expression of LAMA1 mRNA

NCBI chr17:68,004,129...68,129,640
Ensembl chr17:68,004,254...68,129,642

G

laminin, alpha 4

affects expression

Busulfan affects the expression of LAMA4 mRNA

NCBI chr10:38,841,511...38,986,184
Ensembl chr10:38,841,511...38,986,184

G

luteinizing hormone beta

decreases expression

Busulfan results in decreased expression of LHB protein

NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321

G

microtubule-associated protein 1 light chain 3 beta

increases expression
multiple interactions

Busulfan results in increased expression of MAP1LC3B protein
3-methyladenine inhibits the reaction [Busulfan results in increased expression of MAP1LC3B protein]

NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499

G

mitogen-activated protein kinase 1

increases activity

Busulfan results in increased activity of MAPK1 protein

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mitogen-activated protein kinase 3

increases activity

Busulfan results in increased activity of MAPK3 protein

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

microsomal glutathione S-transferase 2

decreases response to substance

MGST2 protein results in decreased susceptibility to Busulfan

NCBI chr 3:51,544,179...51,590,096
Ensembl chr 3:51,567,781...51,590,098

G

metal response element binding transcription factor 1

decreases expression

Busulfan results in decreased expression of MTF1 mRNA

NCBI chr 4:124,696,342...124,743,593
Ensembl chr 4:124,695,897...124,743,593

G

myelocytomatosis oncogene

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of MYC protein

NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223

G

nanos C2HC-type zinc finger 2

decreases expression

Busulfan results in decreased expression of NANOS2 mRNA; Busulfan results in decreased expression of NANOS2 protein

NCBI chr 7:18,721,449...18,722,887
Ensembl chr 7:18,721,325...18,722,887

G

nanos C2HC-type zinc finger 3

decreases expression

Busulfan results in decreased expression of NANOS3 mRNA

NCBI chr 8:84,900,359...84,911,396
Ensembl chr 8:84,900,360...84,911,846

G

nuclear receptor coactivator 4

multiple interactions
increases expression

3-methyladenine inhibits the reaction [Busulfan results in increased expression of NCOA4 protein]

NCBI chr14:31,881,884...31,901,210
Ensembl chr14:31,881,822...31,901,812

G

nuclear factor, erythroid derived 2, like 2

decreases expression
increases expression
multiple interactions

Busulfan results in decreased expression of NFE2L2 protein
Busulfan results in increased expression of NFE2L2 mRNA
Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]

PMID:32416107 PMID:35641671

NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985

G

nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105

increases expression

Busulfan results in increased expression of NFKB1 mRNA

NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308

G

nucleophosmin 1

multiple interactions

NPM1 gene mutant form results in increased susceptibility to [Busulfan co-treated with Idarubicin]

NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206

G

occludin

decreases expression
multiple interactions

Busulfan results in decreased expression of OCLN mRNA; Busulfan results in decreased expression of OCLN protein
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein]

NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226

G

poly (ADP-ribose) polymerase family, member 1

multiple interactions
increases cleavage

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; [decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein]
Busulfan results in increased cleavage of PARP1 protein

PMID:18339423 PMID:19732952 PMID:20933509

NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819

G

prohibitin 1

affects expression

Busulfan affects the expression of PHB1 mRNA

NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599

G

peroxisome proliferator activated receptor gamma

affects expression

Busulfan affects the expression of PPARG mRNA

NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360

G

prostaglandin-endoperoxide synthase 2

increases expression
multiple interactions

Busulfan results in increased expression of PTGS2 mRNA
ferrostatin-1 inhibits the reaction [Busulfan results in increased expression of PTGS2 mRNA]

PMID:12966370 PMID:32416107

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

pseudouridylate synthase 7

increases expression

Busulfan results in increased expression of PUS7 mRNA

NCBI chr 5:23,945,163...23,988,709
Ensembl chr 5:23,945,646...23,988,709

G

RAD51 recombinase

decreases expression

Busulfan results in decreased expression of RAD51 mRNA

NCBI chr 2:118,943,295...118,966,554
Ensembl chr 2:118,943,274...118,977,926

G

RB transcriptional corepressor 1

decreases phosphorylation

Busulfan results in decreased phosphorylation of RB1 protein

NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262

G

spermidine/spermine N1-acetyl transferase 2

increases expression

Busulfan results in increased expression of SAT2 mRNA; Busulfan results in increased expression of SAT2 protein

NCBI chr11:69,512,824...69,514,857
Ensembl chr11:69,512,850...69,514,696

G

serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1

affects expression

Busulfan affects the expression of SERPINC1 protein

NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433

G

serine (or cysteine) peptidase inhibitor, clade E, member 1

increases expression
multiple interactions

Busulfan results in increased expression of SERPINE1 mRNA; Busulfan results in increased expression of SERPINE1 protein
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of SERPINE1 mRNA]

NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122

G

solute carrier family 40 (iron-regulated transporter), member 1

decreases expression
multiple interactions

Busulfan results in decreased expression of SLC40A1 protein
Deferoxamine inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]

NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683

G

solute carrier family 7 (cationic amino acid transporter, y+ system), member 11

multiple interactions
decreases expression

3-methyladenine inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein]; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC7A11 mRNA]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein]
Busulfan results in decreased expression of SLC7A11 mRNA; Busulfan results in decreased expression of SLC7A11 protein

NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063

G

structural maintenance of chromosomes 1A

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC1A protein

NCBI chr X:150,799,386...150,844,969
Ensembl chr X:150,799,424...150,845,690

G

structural maintenance of chromosomes 3

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC3 protein

NCBI chr19:53,588,827...53,634,262
Ensembl chr19:53,588,829...53,634,264

G

sequestosome 1

multiple interactions
decreases expression

3-methyladenine inhibits the reaction [Busulfan results in decreased expression of SQSTM1 protein]

NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654

G

signal transducer and activator of transcription 1

affects expression

Busulfan affects the expression of STAT1 mRNA

NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024

G

signal transducer and activator of transcription 2

decreases expression

Busulfan results in decreased expression of STAT2 mRNA

NCBI chr10:128,106,367...128,128,722
Ensembl chr10:128,106,428...128,128,718

G

stimulated by retinoic acid gene 8

decreases expression

Busulfan results in decreased expression of STRA8 mRNA

NCBI chr 6:34,897,098...34,916,279
Ensembl chr 6:34,897,098...34,916,279

G

tissue factor pathway inhibitor

decreases expression

Busulfan results in decreased expression of TFPI mRNA

NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119

G

transferrin receptor

decreases expression
multiple interactions

Busulfan results in decreased expression of TFRC protein
Deferoxamine promotes the reaction [Busulfan results in decreased expression of TFRC protein]

NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612

G

transforming growth factor, beta 1

increases expression
multiple interactions

Busulfan results in increased expression of TGFB1 mRNA
pirfenidone inhibits the reaction [Busulfan results in increased expression of TGFB1 mRNA]

PMID:22286157 PMID:37597760

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

G

thrombospondin 1

increases expression

Busulfan results in increased expression of THBS1 mRNA

NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614

G

tissue inhibitor of metalloproteinase 1

increases expression

Busulfan results in increased expression of TIMP1 mRNA

NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974

G

tumor necrosis factor

increases expression

Busulfan results in increased expression of TNF mRNA

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

transferrin

multiple interactions
increases expression

4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of TF mRNA]
Busulfan results in increased expression of TF mRNA; Busulfan results in increased expression of TF protein

PMID:12966370 PMID:22286157

NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643

G

transformation related protein 53

multiple interactions
increases expression

Busulfan affects the phosphorylation of and affects the activity of TP53 protein
Busulfan results in increased expression of TP53 mRNA

PMID:16882877 PMID:35641671

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

thioredoxin reductase 1

decreases activity

Busulfan results in decreased activity of TXNRD1 protein

NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546

G

X-box binding protein 1

affects expression

Busulfan affects the expression of XBP1 mRNA

NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893

G

X-linked inhibitor of apoptosis

multiple interactions

[clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of XIAP protein

NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533

G

zinc finger and BTB domain containing 16

increases expression

Busulfan results in increased expression of ZBTB16 mRNA

NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522

butan-2-ol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cholinergic receptor nicotinic alpha 2 subunit

multiple interactions

2-butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]

NCBI chr14:66,370,685...66,390,397
Ensembl chr14:66,372,488...66,390,397

G

cholinergic receptor, nicotinic, beta polypeptide 4

multiple interactions

2-butanol affects the reaction [Acetylcholine promotes the reaction [[CHRNA2 protein binds to CHRNB4 protein] which results in increased transport of Barium]]

NCBI chr 9:54,935,438...54,956,236
Ensembl chr 9:54,935,438...54,956,063

G

eukaryotic translation initiation factor 4E binding protein 1

multiple interactions

2-butanol inhibits the reaction [lysophosphatidic acid results in increased phosphorylation of EIF4EBP1 protein]

NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702

G

growth hormone

affects folding

2-butanol affects the folding of GH1 protein

NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691

butane

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BCL2-associated X protein

increases expression

butane results in increased expression of BAX mRNA

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

fibronectin 1

decreases expression

butane results in decreased expression of FN1 mRNA

NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359

butane-1,3-diol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cytochrome P450, family 2, subfamily e, polypeptide 1

increases activity
increases expression

1,3-butylene glycol results in increased activity of CYP2E1 protein
1,3-butylene glycol results in increased expression of CYP2E1 protein

NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900

butane-2,3-diol

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

aldo-keto reductase family 1 member B

multiple interactions

[AKR1B1 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2,3-butylene glycol

NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413

G

aldo-keto reductase family 1, member B10

multiple interactions

[AKR1B10 protein results in increased reduction of Acetoin] which results in increased chemical synthesis of 2,3-butylene glycol

NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885

G

aldehyde dehydrogenase 2, mitochondrial

increases metabolic processing

ALDH2 protein results in increased metabolism of 2,3-butylene glycol

NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887

carbon dioxide

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

thymoma viral proto-oncogene 1

multiple interactions
increases expression

3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of AKT1 protein]

NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318

G

B cell leukemia/lymphoma 2

multiple interactions
increases expression

3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of BCL2 protein]

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

brain derived neurotrophic factor

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein]

NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352

G

calcitonin/calcitonin-related polypeptide, alpha

multiple interactions
increases secretion

Carbon Dioxide inhibits the reaction [Capsaicin results in increased secretion of CALCA protein]; Carbon Dioxide inhibits the reaction [Potassium Chloride results in increased secretion of CALCA protein]; Carbon Dioxide inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in increased secretion of CALCA protein]
Carbon Dioxide results in increased secretion of CALCA protein

NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592

G

calcium/calmodulin-dependent protein kinase II, beta

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein]

NCBI chr11:5,919,642...6,016,401
Ensembl chr11:5,919,644...6,016,362

G

cAMP responsive element binding protein 1

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein]

NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707

G

corticotropin releasing hormone

increases response to substance

CRH protein results in increased susceptibility to Carbon Dioxide

NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560

G

discs large MAGUK scaffold protein 3

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein]

NCBI chr X:99,811,200...99,862,016
Ensembl chr X:99,811,328...99,862,016

G

glutamate receptor, ionotropic, NMDA2B (epsilon 2)

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein]

NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509

G

interleukin 2

multiple interactions
increases expression

3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of IL2 mRNA]; 3-n-butylphthalide promotes the reaction [Carbon Dioxide results in increased expression of IL2 protein]
Carbon Dioxide results in increased expression of IL2 mRNA; Carbon Dioxide results in increased expression of IL2 protein

NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108

G

mitogen-activated protein kinase 1

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK1 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK1 protein]

PMID:24718106 PMID:25004876

NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317

G

mitogen-activated protein kinase 3

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA; [Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of MAPK3 mRNA]; notoginsenoside R1 inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased phosphorylation of MAPK3 protein]

PMID:24718106 PMID:25004876

NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991

G

microRNA 29a

multiple interactions

[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Dioxide] which results in increased expression of MIR29A mRNA

NCBI chr 6:31,039,595...31,039,682
Ensembl chr 6:31,039,595...31,039,682

G

nei endonuclease VIII-like 1 (E. coli)

affects abundance

NEIL1 affects the abundance of Carbon Dioxide

NCBI chr 9:57,050,072...57,055,973
Ensembl chr 9:57,050,084...57,055,589

G

neuroglobin

affects binding

Carbon Dioxide binds to [Heme binds to NGB protein]

NCBI chr12:87,144,305...87,149,313
Ensembl chr12:87,144,305...87,149,313

G

peroxisome proliferator activated receptor alpha

multiple interactions

PPARA protein promotes the reaction [[GW 7647 results in increased oxidation of Palmitic Acid] which results in increased abundance of Carbon Dioxide]

NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020

G

Rap guanine nucleotide exchange factor (GEF) 3

multiple interactions

[RAPGEF3 protein affects the susceptibility to Dietary Fats] which affects the chemical synthesis of Carbon Dioxide

NCBI chr15:97,637,886...97,666,300
Ensembl chr15:97,642,651...97,665,853

G

solute carrier family 9 (sodium/hydrogen exchanger), member 1

affects response to substance

SLC9A1 protein affects the susceptibility to Carbon Dioxide

NCBI chr 4:133,097,022...133,151,013
Ensembl chr 4:133,097,017...133,151,013

G

superoxide dismutase 1, soluble

multiple interactions

[[[Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]] which results in increased reduction of peroxycarbonic acid] which results in increased chemical synthesis of Carbonates; [[Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]] which results in increased reduction of peroxycarbonic acid; [[SOD1 protein results in increased metabolism of Hydrogen Peroxide] results in increased oxidation of [Bicarbonates co-treated with Carbon Dioxide]] which results in increased chemical synthesis of Carbonates; [Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein binds to peroxycarbonic acid]; [Bicarbonates co-treated with Carbon Dioxide] promotes the reaction [SOD1 protein results in increased metabolism of Hydrogen Peroxide]; [SOD1 protein results in increased metabolism of Hydrogen Peroxide] results in increased oxidation of [Bicarbonates co-treated with Carbon Dioxide]

NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217

G

synaptotagmin binding, cytoplasmic RNA interacting protein

multiple interactions

[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Dioxide] which affects the expression of SYNCRIP mRNA

NCBI chr 9:88,331,417...88,364,645
Ensembl chr 9:88,329,062...88,364,627

G

synaptic Ras GTPase activating protein 1 homolog (rat)

multiple interactions

[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein; ifenprodil inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of SYNGAP1 protein]

NCBI chr17:27,160,186...27,191,408
Ensembl chr17:27,160,227...27,191,408

G

triosephosphate isomerase 1

increases expression

Carbon Dioxide results in increased expression of TPI1 mRNA

NCBI chr 6:124,787,549...124,791,121
Ensembl chr 6:124,787,549...124,791,259

G

thyrotropin releasing hormone

increases response to substance

TRH protein results in increased susceptibility to Carbon Dioxide

NCBI chr 6:92,219,042...92,221,631
Ensembl chr 6:92,219,042...92,221,631

G

transient receptor potential cation channel, subfamily A, member 1

increases activity

Carbon Dioxide results in increased activity of TRPA1 protein

NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086

G

transient receptor potential cation channel, subfamily V, member 1

affects response to substance

TRPV1 protein affects the susceptibility to Carbon Dioxide

NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068

DAPT

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

actin alpha 2, smooth muscle, aorta

multiple interactions

1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased expression of ACTA2 protein]]

NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990

G

thymoma viral proto-oncogene 1

multiple interactions

1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one promotes the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of AKT1 protein]

NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318

G

amyloid beta precursor protein

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased secretion of APP protein modified form]

NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654

G

BCL2-associated X protein

increases expression
multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of BAX protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]

PMID:21209419 PMID:34897970

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

B cell leukemia/lymphoma 2

decreases expression
multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]

PMID:21209419 PMID:34897970

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

bone morphogenetic protein 6

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA]

NCBI chr13:38,529,098...38,684,283
Ensembl chr13:38,529,083...38,684,278

G

caspase 3

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of and results in increased activity of CASP3 protein

PMID:21209419 PMID:34897970

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 9

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]]

NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287

G

cyclin D1

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of CCND1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of CCND1 mRNA]

NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662

G

cadherin 1

multiple interactions

[N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester co-treated with 1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one] inhibits the reaction [polyhexamethyleneguanidine results in decreased expression of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased secretion of CDH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased cleavage of CDH1 protein]

PMID:18791180 PMID:31348943

NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878

G

cadherin 2

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of CDH2 protein]

NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303

G

colony stimulating factor 1 (macrophage)

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of CSF1 mRNA]

NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785

G

enolase 2, gamma neuronal

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of ENO2 mRNA]

NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636

G

FMS-like tyrosine kinase 1

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of FLT1 protein]

NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821

G

forkhead box O3

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein]

NCBI chr10:42,057,841...42,152,691
Ensembl chr10:42,057,837...42,152,751

G

hes family bHLH transcription factor 1

multiple interactions
decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased expression of HES1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of HES1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HES1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of HES1 protein]

PMID:19160421 PMID:24223152 PMID:25005833 PMID:25108166 PMID:32041402 More...

NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614

G

hairy/enhancer-of-split related with YRPW motif 1

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY1 mRNA]

NCBI chr 3:8,728,419...8,732,098
Ensembl chr 3:8,728,419...8,732,316

G

hairy/enhancer-of-split related with YRPW motif 2

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalein results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [baicalin results in increased expression of HEY2 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Niclosamide results in increased expression of HEY2 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of HEY2 mRNA]

PMID:19160421 PMID:32041402

NCBI chr10:30,708,355...30,718,779
Ensembl chr10:30,708,355...30,718,797

G

hypoxia inducible factor 1, alpha subunit

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Hydrogen Peroxide results in increased expression of HIF1A protein]

NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304

G

high mobility group box 1

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of HMGB1 protein]

NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299

G

interleukin 10

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL10 mRNA]

NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711

G

interleukin 1 beta

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Diethylhexyl Phthalate results in increased expression of IL1B protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL1B mRNA]

PMID:21843347 PMID:24223152 PMID:36988346

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

interleukin 6

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of IL6 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]

PMID:21843347 PMID:24223152

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

integrin alpha M

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of ITGAM protein]

NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663

G

involucrin

decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL protein

NCBI chr 3:92,478,206...92,481,097
Ensembl chr 3:92,478,209...92,481,042

G

jagged 1

decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of JAG1 protein

NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564

G

keratin 1

multiple interactions
decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT1 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT1 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT1 mRNA

PMID:18633435 PMID:23566955

NCBI chr15:101,753,861...101,759,221
Ensembl chr15:101,753,861...101,759,229

G

keratin 10

multiple interactions
decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [BMP6 protein results in increased expression of KRT10 mRNA]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [U 0126 results in increased expression of KRT10 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of KRT10 protein

PMID:18633435 PMID:23566955

NCBI chr11:99,276,080...99,288,631
Ensembl chr11:99,276,080...99,280,190

G

leucine rich repeat containing G protein coupled receptor 5

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of LGR5 mRNA]

NCBI chr10:115,286,219...115,423,685
Ensembl chr10:115,286,216...115,423,685

G

microtubule-associated protein 2

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of MAP2 mRNA]

NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742

G

transformed mouse 3T3 cell double minute 2

multiple interactions
increases expression

Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein]

NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663

G

microRNA 141

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in decreased expression of BCL2 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of BAX protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP3 protein modified form]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [[Polyribonucleotides results in decreased expression of MIR141 mRNA] inhibits the reaction [Palmitic Acid results in increased expression of CASP9 protein modified form]]

NCBI chr 6:124,694,877...124,694,948
Ensembl chr 6:124,694,877...124,694,948

G

myeloid differentiation primary response gene 88

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of MYD88 mRNA]

NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477

G

nitric oxide synthase 2, inducible

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of NOS2 mRNA]

NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080

G

notch 1

multiple interactions
decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased expression of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium Chloride results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Hydrogen Peroxide results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [phenethyl isothiocyanate results in increased cleavage of and results in increased activity of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one inhibits the reaction [polyhexamethyleneguanidine results in increased cleavage of NOTCH1 protein]]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of NOTCH1 protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Tunicamycin results in increased cleavage of NOTCH1 protein]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [Oxygen deficiency results in increased expression of NOTCH1 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein modified form

PMID:18633435 PMID:22039516 PMID:22115781 PMID:24223152 PMID:25108166 More...

NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675

G

notch 2

multiple interactions
decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased cleavage of and results in decreased activity of NOTCH2 protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH2 protein

PMID:22039516 PMID:36988346

NCBI chr 3:97,920,854...98,057,683
Ensembl chr 3:97,920,843...98,057,677

G

notch 3

decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH3 protein

NCBI chr17:32,339,794...32,385,869
Ensembl chr17:32,339,794...32,385,826

G

notch 4

decreases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH4 protein

NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477

G

NUMB endocytic adaptor protein

increases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of NUMB protein

NCBI chr12:83,840,808...83,968,708
Ensembl chr12:83,840,808...83,968,708

G

promyelocytic leukemia

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]]

NCBI chr 9:58,125,359...58,157,077
Ensembl chr 9:58,125,359...58,157,069

G

peroxisome proliferator activated receptor alpha

multiple interactions
increases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of PPARA protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of PPARA protein

NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020

G

prostaglandin-endoperoxide synthase 2

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cadmium results in increased expression of PTGS2 mRNA]

NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978

G

retinoic acid receptor, alpha

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in increased degradation of [PML protein mutant form binds to RARA protein mutant form]]

NCBI chr11:98,818,626...98,865,768
Ensembl chr11:98,818,644...98,865,768

G

recombination signal binding protein for immunoglobulin kappa J region

multiple interactions
increases expression

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RBPJ mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of RBPJ protein
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Cycloheximide results in decreased expression of RBPJ protein]

PMID:22302987 PMID:24223152

NCBI chr 5:53,713,121...53,814,787
Ensembl chr 5:53,623,494...53,814,704

G

v-rel reticuloendotheliosis viral oncogene homolog A (avian)

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency affects the localization of RELA protein modified form]; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of RELA protein]

NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158

G

transforming growth factor, beta 1

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TGFB1 mRNA]

NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502

G

toll-like receptor 4

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TLR4 mRNA]

NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521

G

tumor necrosis factor

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TNF mRNA]

NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983

G

TNF receptor-associated factor 6

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 protein]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Oxygen deficiency results in increased expression of TRAF6 mRNA]

NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014

G

transformation related protein 53

decreases expression
multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein
Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of TP53 protein]

NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699

G

tubulin, beta 3 class III

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester promotes the reaction [rhodioloside results in increased expression of TUBB3 mRNA]

NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754

G

vascular endothelial growth factor A

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of VEGFA protein]

NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295

G

villin 1

multiple interactions

N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [tetrabromobisphenol A results in increased expression of VIL1 mRNA]

NCBI chr 1:74,448,543...74,474,719
Ensembl chr 1:74,448,535...74,474,718

diisobutyl phthalate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

nonagouti

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of A mRNA

NCBI chr 2:154,792,519...154,892,932
Ensembl chr 2:154,633,322...154,892,932

G

alpha 1,4-galactosyltransferase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of A4GALT mRNA

NCBI chr15:83,110,923...83,135,930
Ensembl chr15:83,110,923...83,135,975

G

ATP-binding cassette, sub-family A member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ABCA1 mRNA

NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895

G

ATP binding cassette subfamily G member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ABCG1 mRNA

NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962

G

ATP binding cassette subfamily G member 2 (Junior blood group)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ABCG2 mRNA

NCBI chr 6:58,561,476...58,669,436
Ensembl chr 6:58,561,508...58,672,661

G

acetyl-CoA acyltransferase 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACAA2 mRNA

NCBI chr18:74,912,283...74,939,278
Ensembl chr18:74,912,268...74,939,279

G

acyl-CoA synthetase bubblegum family member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSBG1 mRNA

NCBI chr 9:54,512,163...54,569,169
Ensembl chr 9:54,512,161...54,569,154

G

acyl-CoA synthetase family member 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSF2 mRNA

NCBI chr11:94,447,928...94,492,822
Ensembl chr11:94,447,928...94,492,697

G

acyl-CoA synthetase short-chain family member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA

NCBI chr 2:150,460,031...150,510,160
Ensembl chr 2:150,460,025...150,510,420

G

ADAM metallopeptidase with thrombospondin type 1 motif 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]

PMID:33316053 PMID:37552060

NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001

G

ADAM metallopeptidase with thrombospondin type 1 motif 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ADAMTS2 mRNA

NCBI chr11:50,492,912...50,698,400
Ensembl chr11:50,492,911...50,698,400

G

adhesion G protein-coupled receptor L1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ADGRL1 mRNA

NCBI chr 8:84,626,598...84,668,583
Ensembl chr 8:84,626,734...84,668,583

G

adiponectin, C1Q and collagen domain containing

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of ADIPOQ mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ADIPOQ protein

PMID:37021957 PMID:38954831

NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778

G

adrenergic receptor, beta 3

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of ADRB3 mRNA

NCBI chr 8:27,715,804...27,720,833
Ensembl chr 8:27,715,804...27,740,644

G

adenylate kinase 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of AK5 mRNA

NCBI chr 3:152,168,461...152,373,992
Ensembl chr 3:152,168,452...152,373,997

G

A kinase anchor protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AKAP1 mRNA

NCBI chr11:88,721,618...88,755,426
Ensembl chr11:88,721,618...88,755,412

G

aldehyde dehydrogenase family 1, subfamily A1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDH1A1 mRNA

NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829

G

aldehyde dehydrogenase family 1, subfamily A2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ALDH1A2 mRNA

NCBI chr 9:71,123,071...71,203,525
Ensembl chr 9:71,123,071...71,203,525

G

aldehyde dehydrogenase 2, mitochondrial

decreases expression

diisobutyl phthalate results in decreased expression of ALDH2 mRNA

NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887

G

aldolase C, fructose-bisphosphate

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ALDOC mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ALDOC protein

PMID:31199487 PMID:37690569

NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607

G

anti-Mullerian hormone type 2 receptor

increases expression

diisobutyl phthalate results in increased expression of AMHR2 mRNA

NCBI chr15:102,353,437...102,363,075
Ensembl chr15:102,353,802...102,363,068

G

adenosine monophosphate deaminase 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AMPD3 mRNA

NCBI chr 7:110,367,291...110,411,612
Ensembl chr 7:110,367,413...110,411,612

G

angiopoietin 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ANGPT2 protein

NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578

G

angiopoietin-like 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of ANGPTL3 protein

NCBI chr 4:98,919,191...98,926,429
Ensembl chr 4:98,919,191...98,934,348

G

angiopoietin-like 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of ANGPTL4 mRNA

NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804

G

ankyrin repeat domain 50

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANKRD50 mRNA

NCBI chr 3:38,503,408...38,539,005
Ensembl chr 3:38,503,408...38,538,993

G

alanyl aminopeptidase, membrane

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANPEP mRNA

NCBI chr 7:79,471,551...79,497,958
Ensembl chr 7:79,471,551...79,510,807

G

anthrax toxin receptor 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ANTXR1 mRNA

NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803

G

APC regulator of WNT signaling pathway 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APC2 mRNA

NCBI chr10:80,131,790...80,154,091
Ensembl chr10:80,131,811...80,154,097

G

amyloid beta precursor like protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APLP1 mRNA

NCBI chr 7:30,134,405...30,144,960
Ensembl chr 7:30,134,407...30,144,960

G

amyloid beta precursor-like protein 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APLP2 mRNA

NCBI chr 9:31,060,853...31,123,144
Ensembl chr 9:31,060,853...31,123,111

G

apolipoprotein E

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of APOE mRNA

NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113

G

aquaporin 7

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of AQP7 mRNA

NCBI chr 4:41,033,074...41,048,237
Ensembl chr 4:41,033,074...41,048,139

G

androgen receptor

affects binding
multiple interactions

diisobutyl phthalate binds to AR protein
diisobutyl phthalate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; diisobutyl phthalate inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]

PMID:14565775 PMID:15840436 PMID:28571686

NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821

G

Rho GTPase activating protein 18

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA

NCBI chr10:26,648,363...26,794,644
Ensembl chr10:26,629,417...26,794,644

G

Rho GTPase activating protein 6

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP6 mRNA

NCBI chr X:167,578,091...168,087,436
Ensembl chr X:167,578,095...168,087,431

G

Rho/Rac guanine nucleotide exchange factor 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA

NCBI chr 3:88,500,427...88,556,839
Ensembl chr 3:88,513,273...88,555,359

G

aryl hydrocarbon receptor nuclear translocator 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ARNT2 mRNA

NCBI chr 7:83,895,486...84,059,201
Ensembl chr 7:83,895,486...84,059,384

G

arrestin domain containing 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARRDC3 mRNA

NCBI chr13:81,031,508...81,044,161
Ensembl chr13:81,031,503...81,044,161

G

arrestin domain containing 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARRDC4 mRNA

NCBI chr 7:68,386,742...68,398,986
Ensembl chr 7:68,386,743...68,398,989

G

adipocyte-related X-chromosome expressed sequence 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARXES2 mRNA

NCBI chr X:134,894,569...134,896,108
Ensembl chr X:134,894,573...134,896,104

G

astrotactin 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN1 mRNA

NCBI chr 1:158,189,647...158,519,351
Ensembl chr 1:158,189,843...158,519,351

G

astrotactin 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA

NCBI chr 4:65,299,040...66,322,774
Ensembl chr 4:65,299,040...66,322,848

G

activating transcription factor 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ATF3 mRNA

NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236

G

ATPase, class V, type 10D

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ATP10D mRNA

NCBI chr 5:72,360,672...72,456,114
Ensembl chr 5:72,360,672...72,456,118

G

ATPase, Na+/K+ transporting, alpha 3 polypeptide

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ATP1A3 mRNA

NCBI chr 7:24,677,592...24,705,338
Ensembl chr 7:24,677,592...24,705,383

G

beta-3-glucosyltransferase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of B3GLCT mRNA

NCBI chr 5:149,601,565...149,686,064
Ensembl chr 5:149,601,695...149,686,064

G

BCL2-associated X protein

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BAX mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BAX mRNA

PMID:28013214 PMID:37021957

NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322

G

basal cell adhesion molecule

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BCAM mRNA

NCBI chr 7:19,490,063...19,504,457
Ensembl chr 7:19,490,056...19,504,941

G

branched chain aminotransferase 1, cytosolic

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BCAT1 mRNA

NCBI chr 6:144,939,561...145,021,883
Ensembl chr 6:144,939,561...145,021,910

G

B cell leukemia/lymphoma 2

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA

PMID:28013214 PMID:35762964 PMID:37021957

NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004

G

Bcl2-like 10

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of BCL2L10 mRNA

NCBI chr 9:75,255,040...75,258,922
Ensembl chr 9:75,255,040...75,258,931

G

B cell leukemia/lymphoma 6

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BCL6 mRNA

NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602

G

brain derived neurotrophic factor

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BDNF mRNA

NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352

G

BEN domain containing 6

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA

NCBI chr 1:33,891,133...33,946,925
Ensembl chr 1:33,891,133...33,946,897

G

brain expressed X-linked 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BEX2 mRNA

NCBI chr X:135,114,721...135,116,262
Ensembl chr X:135,114,721...135,116,262

G

basic helix-loop-helix family, member e40

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHLHE40 mRNA

NCBI chr 6:108,637,590...108,643,886
Ensembl chr 6:108,637,590...108,643,886

G

basic helix-loop-helix family, member e41

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHLHE41 mRNA

NCBI chr 6:145,803,969...145,811,146
Ensembl chr 6:145,803,969...145,811,284

G

betaine-homocysteine methyltransferase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BHMT mRNA

NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469

G

BH3 interacting domain death agonist

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BID mRNA

NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814

G

BCL2/adenovirus E1B interacting protein 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BNIP3 mRNA

NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248

G

2,3-bisphosphoglycerate mutase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BPGM mRNA

NCBI chr 6:34,453,291...34,482,071
Ensembl chr 6:34,453,142...34,482,548

G

BR serine/threonine kinase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BRSK1 mRNA

NCBI chr 7:4,693,635...4,718,996
Ensembl chr 7:4,693,603...4,718,996

G

BTG anti-proliferation factor 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BTG2 mRNA

NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858

G

basic leucine zipper and W2 domains 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of BZW1 mRNA

NCBI chr 1:58,432,057...58,446,513
Ensembl chr 1:58,432,057...58,446,512

G

calcium channel, voltage-dependent, gamma subunit 7

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CACNG7 mRNA

NCBI chr 7:3,381,341...3,416,737
Ensembl chr 7:3,381,471...3,416,737

G

cell adhesion molecule 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADM3 mRNA

NCBI chr 1:173,161,825...173,195,214
Ensembl chr 1:173,160,825...173,195,261

G

Ca2+-dependent secretion activator

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CADPS mRNA

NCBI chr14:9,646,424...10,097,203
Ensembl chr14:9,646,684...10,097,200

G

calcium/calmodulin-dependent protein kinase IV

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAMK4 mRNA

NCBI chr18:33,067,995...33,328,820
Ensembl chr18:33,067,984...33,324,281

G

calcium/calmodulin-dependent protein kinase kinase 1, alpha

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAMKK1 mRNA

NCBI chr11:72,906,869...72,932,899
Ensembl chr11:72,909,834...72,932,899

G

cullin associated and neddylation dissociated 2 (putative)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAND2 mRNA

NCBI chr 6:115,751,518...115,782,516
Ensembl chr 6:115,751,499...115,782,518

G

caspase 2

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CASP2 mRNA

NCBI chr 6:42,241,942...42,259,442
Ensembl chr 6:42,241,919...42,259,442

G

caspase 3

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CASP3 mRNA

NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724

G

caspase 8

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CASP8 mRNA

NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662

G

catalase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CAT mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CAT mRNA

PMID:28013214 PMID:39150890

NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505

G

cystathionine beta-synthase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CBS mRNA

NCBI chr17:31,831,602...31,856,170
Ensembl chr17:31,827,868...31,856,212

G

coiled-coil domain containing 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CCDC3 mRNA

NCBI chr 2:5,142,587...5,235,682
Ensembl chr 2:5,142,587...5,235,689

G

C-C motif chemokine ligand 2

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL2 mRNA

NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279

G

C-C motif chemokine ligand 5

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CCL5 mRNA

NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344

G

cellular communication network factor 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CCN4 mRNA

NCBI chr15:66,763,337...66,795,050
Ensembl chr15:66,763,169...66,795,050

G

cyclin D2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CCND2 mRNA

NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156

G

CD36 molecule

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CD36 mRNA

NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799

G

CD93 antigen

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of CD93 protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CD93 mRNA

PMID:38954831 PMID:39150890

NCBI chr 2:148,278,571...148,285,455
Ensembl chr 2:148,278,560...148,285,483

G

cadherin-related family member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDHR1 mRNA

NCBI chr14:36,799,806...36,820,304
Ensembl chr14:36,799,814...36,820,304

G

cyclin dependent kinase 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDK4 mRNA

NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789

G

cyclin dependent kinase 5, regulatory subunit 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDK5R1 mRNA

NCBI chr11:80,367,849...80,372,010
Ensembl chr11:80,367,849...80,372,010

G

cyclin dependent kinase inhibitor 1A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CDKN1A mRNA

PMID:33316053 PMID:35762964

NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701

G

cyclin dependent kinase inhibitor 1B

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CDKN1B mRNA

NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476

G

cyclin dependent kinase inhibitor 1C

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDKN1C mRNA

NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787

G

cyclin dependent kinase inhibitor 2A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CDKN2A mRNA

NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890

G

cysteine dioxygenase 1, cytosolic

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CDO1 mRNA

NCBI chr18:46,846,260...46,861,569
Ensembl chr18:46,846,260...46,861,462

G

CCAAT/enhancer binding protein alpha

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA

NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353

G

cadherin, EGF LAG seven-pass G-type receptor 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CELSR3 mRNA

NCBI chr 9:108,703,244...108,730,168
Ensembl chr 9:108,703,519...108,730,168

G

centromere protein M

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CENPM mRNA

NCBI chr15:82,115,694...82,128,974
Ensembl chr15:82,117,980...82,128,949

G

ceramide kinase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA

NCBI chr15:86,023,302...86,070,537
Ensembl chr15:86,023,329...86,070,342

G

cilia and flagella associated protein 299

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CFAP299 mRNA

NCBI chr 5:98,476,998...98,949,912
Ensembl chr 5:98,477,163...98,949,906

G

glycoprotein hormones, alpha subunit

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PLAT mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINB2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of SERPINE1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of TIMP1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of SLCO2A1 mRNA]
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein affects the expression of ADAMTS1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of HSD3B2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of PTX3 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of RGS2 mRNA]; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of STAR mRNA]; Cyclic AMP inhibits the reaction [[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of PGR mRNA]]

PMID:33316053 PMID:37552060

NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370

G

chromogranin A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGA mRNA

NCBI chr12:102,521,200...102,531,286
Ensembl chr12:102,521,228...102,531,287

G

chromogranin B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CHGB mRNA

NCBI chr 2:132,623,562...132,636,999
Ensembl chr 2:132,623,198...132,636,999

G

Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CITED1 mRNA

NCBI chr X:101,290,984...101,295,787
Ensembl chr X:101,290,987...101,295,787

G

CAP-GLY domain containing linker protein 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CLIP3 mRNA

NCBI chr 7:29,991,120...30,007,792
Ensembl chr 7:29,991,153...30,007,792

G

calsyntenin 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CLSTN3 mRNA

NCBI chr 6:124,407,715...124,441,743
Ensembl chr 6:124,407,540...124,441,753

G

cytidine monophospho-N-acetylneuraminic acid hydroxylase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CMAH mRNA

NCBI chr13:24,511,387...24,661,272
Ensembl chr13:24,511,387...24,661,360

G

carboxymethylenebutenolidase homolog

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CMBL mRNA

NCBI chr15:31,565,314...31,590,266
Ensembl chr15:31,565,535...31,590,265

G

contactin 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CNTN2 mRNA

NCBI chr 1:132,437,163...132,470,989
Ensembl chr 1:132,437,165...132,470,994

G

contactin associated protein-like 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CNTNAP1 mRNA

NCBI chr11:101,065,429...101,081,550
Ensembl chr11:101,061,349...101,081,550

G

contactin associated protein-like 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CNTNAP2 mRNA

NCBI chr 6:45,036,995...47,278,330
Ensembl chr 6:45,036,291...47,281,147

G

collagen, type X, alpha 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL10A1 mRNA

NCBI chr10:34,265,977...34,273,081
Ensembl chr10:34,265,977...34,273,081

G

collagen, type XVIII, alpha 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of COL18A1 protein

NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382

G

collagen, type I, alpha 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL1A1 mRNA

NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868

G

collagen, type III, alpha 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL3A1 mRNA

NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866

G

collagen, type VI, alpha 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A1 mRNA

NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002

G

collagen, type VI, alpha 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA

NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464

G

collagen, type VIII, alpha 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL8A1 mRNA

NCBI chr16:57,444,619...57,575,100
Ensembl chr16:57,444,621...57,575,100

G

catechol-O-methyltransferase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COMT mRNA

NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602

G

copine VIII

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CPNE8 mRNA

NCBI chr15:90,371,684...90,563,591
Ensembl chr15:90,371,685...90,563,635

G

carboxypeptidase Z

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CPZ mRNA

NCBI chr 5:35,659,562...35,682,970
Ensembl chr 5:35,659,562...35,683,042

G

cellular repressor of E1A-stimulated genes 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CREG1 mRNA

NCBI chr 1:165,591,327...165,602,878
Ensembl chr 1:165,591,315...165,602,877

G

collapsin response mediator protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CRMP1 mRNA

NCBI chr 5:37,399,402...37,449,507
Ensembl chr 5:37,399,284...37,449,477

G

C-reactive protein, pentraxin-related

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of CRP protein

NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598

G

colony stimulating factor 1 (macrophage)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CSF1 protein

NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785

G

cysteine-serine-rich nuclear protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA

NCBI chr 9:119,800,229...119,813,808
Ensembl chr 9:119,800,229...119,813,724

G

C-X-C motif chemokine ligand 12

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CXCL12 protein

NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328

G

C-X-C motif chemokine ligand 13

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of CXCL13 protein

NCBI chr 5:96,104,785...96,108,927
Ensembl chr 5:96,104,810...96,108,927

G

C-X-C motif chemokine ligand 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CXCL5 mRNA

NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483

G

C-X-C motif chemokine receptor 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CXCR4 mRNA]

NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030

G

cytochrome b5 type A (microsomal)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYB5A mRNA

NCBI chr18:84,869,463...84,897,996
Ensembl chr18:84,856,829...84,897,996

G

cytochrome P450, family 11, subfamily a, polypeptide 1

decreases expression
multiple interactions

diisobutyl phthalate results in decreased expression of CYP11A1 mRNA; diisobutyl phthalate results in decreased expression of CYP11A1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of CYP11A1 mRNA]
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP11A1 mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11A1 mRNA

PMID:16458459 PMID:21633115 PMID:22112501 PMID:28013214 PMID:30802670 More...

NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306

G

cytochrome P450, family 11, subfamily b, polypeptide 2

multiple interactions
decreases expression

[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP11B2 mRNA
diisobutyl phthalate results in decreased expression of CYP11B2 mRNA

NCBI chr15:74,722,467...74,728,080
Ensembl chr15:74,722,467...74,728,167

G

cytochrome P450, family 17, subfamily a, polypeptide 1

decreases expression
multiple interactions

diisobutyl phthalate results in decreased expression of CYP17A1 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP17A1 mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA
[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diethyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of CYP17A1 mRNA

PMID:22112501 PMID:28655647 PMID:30802670 PMID:33983380 PMID:37788136

NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611

G

cytochrome P450, family 19, subfamily a, polypeptide 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of CYP19A1 mRNA; [Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of CYP19A1 mRNA

PMID:28013214 PMID:34597818

NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394

G

cytochrome P450, family 26, subfamily b, polypeptide 1

multiple interactions

[diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in increased expression of CYP26B1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP26B1 mRNA

PMID:37788136 PMID:39150890

NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890

G

cytochrome P450, family 2, subfamily f, polypeptide 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CYP2F2 mRNA

NCBI chr 7:26,819,380...26,833,085
Ensembl chr 7:26,819,334...26,833,085

G

cytochrome P450, family 51

decreases expression

diisobutyl phthalate results in decreased expression of CYP51 mRNA

NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746

G

DNA segment, Chr 16, ERATO Doi 472, expressed

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of D16ERTD472E mRNA

NCBI chr16:78,337,224...78,373,576
Ensembl chr16:78,337,226...78,373,596

G

differentiation antagonizing non-protein coding RNA

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DANCR mRNA

NCBI chr 5:74,253,780...74,254,998
Ensembl chr 5:74,253,357...74,284,805

G

DDB1 and CUL4 associated factor 12-like 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DCAF12L1 mRNA

NCBI chr X:43,875,444...43,879,074
Ensembl chr X:43,875,447...43,879,074

G

doublecortin-like kinase 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DCLK3 mRNA

NCBI chr 9:111,268,149...111,318,679
Ensembl chr 9:111,268,149...111,318,186

G

dopa decarboxylase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DDC mRNA

NCBI chr11:11,764,101...11,848,144
Ensembl chr11:11,764,101...11,848,144

G

DNA-damage-inducible transcript 4-like

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DDIT4L mRNA

NCBI chr 3:137,329,433...137,334,093
Ensembl chr 3:137,327,373...137,334,094

G

diacylglycerol kinase, beta

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DGKB mRNA

NCBI chr12:37,930,169...38,684,238
Ensembl chr12:37,867,725...38,684,238

G

D-glutamate cyclase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DGLUCY mRNA

NCBI chr12:100,745,316...100,838,869
Ensembl chr12:100,745,316...100,863,240

G

7-dehydrocholesterol reductase

multiple interactions
decreases expression

[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of DHCR7 mRNA
diisobutyl phthalate results in decreased expression of DHCR7 mRNA

NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147

G

dehydrogenase/reductase 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA

NCBI chr 4:144,618,712...144,654,214
Ensembl chr 4:144,619,397...144,654,779

G

dickkopf WNT signaling pathway inhibitor 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DKK2 mRNA

NCBI chr 3:131,791,027...131,886,065
Ensembl chr 3:131,791,053...131,886,065

G

dynein axonemal assembly factor 10

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of WDR92 mRNA

NCBI chr11:17,161,893...17,185,200
Ensembl chr11:17,132,107...17,183,796

G

delta/notch-like EGF repeat containing

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DNER mRNA

NCBI chr 1:84,347,560...84,673,942
Ensembl chr 1:84,347,560...84,673,942

G

dedicator of cyto-kinesis 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DOCK3 mRNA

NCBI chr 9:106,770,024...107,109,108
Ensembl chr 9:106,770,024...107,109,108

G

double PHD fingers 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DPF1 mRNA

NCBI chr 7:29,003,366...29,017,017
Ensembl chr 7:29,003,376...29,017,668

G

dihydropyrimidinase-like 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DPYSL3 mRNA

NCBI chr18:43,454,044...43,571,354
Ensembl chr18:43,454,049...43,571,351

G

dopamine receptor D4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DRD4 mRNA

NCBI chr 7:140,871,931...140,874,868
Ensembl chr 7:140,871,919...140,876,377

G

dual specificity phosphatase 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DUSP4 mRNA

NCBI chr 8:35,274,448...35,289,106
Ensembl chr 8:35,274,451...35,287,048

G

dynein cytoplasmic 1 intermediate chain 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of DYNC1I1 mRNA

NCBI chr 6:5,725,772...6,028,030
Ensembl chr 6:5,725,639...6,028,039

G

EBP cholestenol delta-isomerase

decreases expression

diisobutyl phthalate results in decreased expression of EBP mRNA

NCBI chr X:8,051,568...8,059,751
Ensembl chr X:8,051,568...8,059,751

G

endothelin 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EDN1 mRNA

NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466

G

endothelin 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of EDN2 mRNA]

NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557

G

Eef1akmt4-endothelin converting enzyme 2 readthrough

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ECE2 mRNA

NCBI chr16:20,430,351...20,464,665
Ensembl chr16:20,430,360...20,464,670

G

early growth response 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EGR1 mRNA

NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037

G

ELAV like RNA binding protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA

NCBI chr 4:91,099,770...91,288,407
Ensembl chr 4:91,139,000...91,289,022

G

ELMO/CED-12 domain containing 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ELMOD1 mRNA

NCBI chr 9:53,818,741...53,882,628
Ensembl chr 9:53,818,741...53,882,585

G

embigin

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EMB mRNA

NCBI chr13:117,357,109...117,410,951
Ensembl chr13:117,345,072...117,410,951

G

epithelial membrane protein 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EMP2 mRNA

NCBI chr16:10,099,613...10,131,832
Ensembl chr16:10,099,613...10,131,832

G

empty spiracles homeobox 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EMX2 mRNA

NCBI chr19:59,447,122...59,453,789
Ensembl chr19:59,446,804...59,453,789

G

ectodermal-neural cortex 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ENC1 mRNA

NCBI chr13:97,377,613...97,389,548
Ensembl chr13:97,377,613...97,389,542

G

ependymin related 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of EPDR1 mRNA

NCBI chr13:19,775,878...19,804,000
Ensembl chr13:19,775,876...19,804,097

G

Eph receptor A4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EPHA4 mRNA

NCBI chr 1:77,343,819...77,491,763
Ensembl chr 1:77,343,822...77,491,725

G

endoplasmic reticulum metallopeptidase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ERMP1 mRNA

NCBI chr19:29,587,276...29,625,815
Ensembl chr19:29,585,614...29,625,815

G

ERBB receptor feedback inhibitor 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ERRFI1 mRNA

NCBI chr 4:150,938,253...150,953,346
Ensembl chr 4:150,938,376...150,953,349

G

espin

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESPN mRNA

NCBI chr 4:152,204,788...152,236,871
Ensembl chr 4:152,204,788...152,236,828

G

estrogen receptor 1 (alpha)

multiple interactions
increases activity

diisobutyl phthalate binds to and results in increased activity of ESR1 protein; diisobutyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [diisobutyl phthalate binds to and results in increased activity of ESR1 protein]
diisobutyl phthalate results in increased activity of ESR1 protein
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ESR1 mRNA

PMID:15840436 PMID:27633901 PMID:28013214 PMID:28571686

NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614

G

estrogen receptor 2 (beta)

multiple interactions
increases activity

diisobutyl phthalate binds to and results in increased activity of ESR2 protein; diisobutyl phthalate inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
diisobutyl phthalate results in increased activity of ESR2 protein

PMID:27633901 PMID:28571686

NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033

G

extended synaptotagmin-like protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ESYT1 mRNA

NCBI chr10:128,346,117...128,361,728
Ensembl chr10:128,345,834...128,361,740

G

electron transferring flavoprotein, dehydrogenase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ETFDH mRNA

NCBI chr 3:79,511,095...79,536,074
Ensembl chr 3:79,511,095...79,536,807

G

ets variant 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ETV5 mRNA

NCBI chr16:22,200,063...22,258,320
Ensembl chr16:22,200,059...22,258,469

G

eva-1 homolog A, regulator of programmed cell death

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EVA1A mRNA

NCBI chr 6:82,018,058...82,070,079
Ensembl chr 6:82,018,024...82,070,080

G

EYA transcriptional coactivator and phosphatase 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of EYA2 mRNA

NCBI chr 2:165,436,892...165,613,645
Ensembl chr 2:165,436,952...165,613,647

G

fatty acid binding protein 5, epidermal

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FABP5 mRNA

NCBI chr 3:10,077,645...10,081,670
Ensembl chr 3:10,077,608...10,081,667

G

fumarylacetoacetate hydrolase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAH mRNA

NCBI chr 7:84,234,367...84,255,150
Ensembl chr 7:84,234,367...84,255,930

G

family with sequence similarity 163, member A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FAM163A mRNA

NCBI chr 1:155,951,702...156,033,027
Ensembl chr 1:155,951,712...156,032,596

G

family with sequence similarity 219, member A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAM219A mRNA

NCBI chr 4:41,517,691...41,569,538
Ensembl chr 4:41,517,691...41,569,538

G

family with sequence similarity 222, member A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAM222A mRNA

NCBI chr 5:114,706,312...114,751,281
Ensembl chr 5:114,706,077...114,751,281

G

fatty acyl CoA reductase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FAR1 mRNA

NCBI chr 7:113,113,008...113,170,713
Ensembl chr 7:113,113,041...113,170,718

G

F-box and leucine-rich repeat protein 7

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA

NCBI chr15:26,540,540...26,895,650
Ensembl chr15:26,540,545...26,895,666

G

Fc receptor, IgG, low affinity III

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FCGR3 mRNA

NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504

G

farnesyl diphosphate synthetase

decreases expression

diisobutyl phthalate results in decreased expression of FDPS mRNA

NCBI chr 3:89,000,895...89,009,274
Ensembl chr 3:89,000,895...89,009,266

G

fasciculation and elongation protein zeta 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FEZ1 mRNA

NCBI chr 9:36,732,694...36,790,220
Ensembl chr 9:36,733,160...36,790,220

G

fibroblast growth factor 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGF11 mRNA

NCBI chr11:69,686,894...69,693,775
Ensembl chr11:69,686,894...69,692,683

G

fibroblast growth factor 2

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of FGF2 mRNA

NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257

G

fibroblast growth factor 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGF5 mRNA

NCBI chr 5:98,402,108...98,424,892
Ensembl chr 5:98,402,043...98,424,889

G

fibroblast growth factor receptor 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FGFR2 mRNA

NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079

G

four and a half LIM domains 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FHL2 mRNA

NCBI chr 1:43,162,233...43,237,501
Ensembl chr 1:43,162,234...43,236,144

G

FK506 binding protein 1b

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FKBP1B mRNA

NCBI chr12:4,883,174...4,891,736
Ensembl chr12:4,883,174...4,891,591

G

folliculin

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FLCN mRNA

NCBI chr11:59,682,234...59,706,138
Ensembl chr11:59,682,234...59,700,842

G

filaggrin

multiple interactions

[FLG gene polymorphism affects the susceptibility to diisobutyl phthalate] which affects the abundance of mono-isobutyl phthalate

NCBI chr 3:93,180,853...93,200,996
Ensembl chr 3:93,180,830...93,200,993

G

FBJ osteosarcoma oncogene B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FOSB mRNA

NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976

G

follicle stimulating hormone beta

multiple interactions

[Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of FSHB protein

NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001

G

follicle stimulating hormone receptor

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FSHR mRNA

NCBI chr17:89,292,380...89,508,103
Ensembl chr17:89,292,380...89,508,103

G

FXYD domain-containing ion transport regulator 7

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of FXYD7 mRNA

NCBI chr 7:30,741,940...30,750,879
Ensembl chr 7:30,741,938...30,750,892

G

frizzled class receptor 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FZD2 mRNA

NCBI chr11:102,495,257...102,498,884
Ensembl chr11:102,495,222...102,498,884

G

frizzled class receptor 8

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FZD8 mRNA

NCBI chr18:9,212,856...9,216,201
Ensembl chr18:9,212,163...9,218,136

G

growth arrest and DNA-damage-inducible 45 alpha

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GADD45A mRNA

NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441

G

polypeptide N-acetylgalactosaminyltransferase 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GALNT4 mRNA

NCBI chr10:98,943,997...98,949,109
Ensembl chr10:98,944,021...98,949,109

G

alpha glucosidase 2 alpha neutral subunit

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GANAB mRNA

NCBI chr19:8,875,440...8,894,098
Ensembl chr19:8,875,435...8,894,036

G

GATA binding protein 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GATA4 mRNA

NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141

G

growth differentiation factor 15

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GDF15 mRNA

NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106

G

glial cell line derived neurotrophic factor family receptor alpha 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA3 mRNA

NCBI chr18:34,822,951...34,853,440
Ensembl chr18:34,822,951...34,853,440

G

glial cell line derived neurotrophic factor family receptor alpha 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GFRA4 mRNA

NCBI chr 2:130,881,552...130,885,008
Ensembl chr 2:130,881,552...130,885,008

G

glycoprotein galactosyltransferase alpha 1, 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GGTA1 mRNA

NCBI chr 2:35,290,191...35,354,393
Ensembl chr 2:35,290,191...35,353,243

G

GLI pathogenesis-related 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GLIPR2 mRNA

NCBI chr 4:43,957,702...43,979,118
Ensembl chr 4:43,957,401...43,979,118

G

glutaminase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GLS mRNA

NCBI chr 1:52,202,608...52,274,168
Ensembl chr 1:52,202,607...52,272,391

G

glucocorticoid modulatory element binding protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GMEB1 mRNA

NCBI chr 4:131,948,336...131,988,919
Ensembl chr 4:131,948,336...131,988,913

G

guanine nucleotide binding protein (G protein), gamma 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GNG2 mRNA

NCBI chr14:19,922,626...20,027,893
Ensembl chr14:19,922,627...20,027,695

G

glycerophosphocholine phosphodiesterase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPCPD1 mRNA

NCBI chr 2:132,371,002...132,420,173
Ensembl chr 2:132,371,002...132,429,649

G

glycerol-3-phosphate dehydrogenase 1 (soluble)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPD1 mRNA

NCBI chr15:99,615,468...99,622,895
Ensembl chr15:99,615,396...99,622,886

G

G protein-coupled receptor 165

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPR165 mRNA

NCBI chr X:95,757,074...95,762,994
Ensembl chr X:95,757,047...95,765,464

G

G-protein coupled receptor 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPR3 mRNA

NCBI chr 4:132,936,651...132,939,847
Ensembl chr 4:132,936,651...132,939,847

G

G protein regulated inducer of neurite outgrowth 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GPRIN2 mRNA

NCBI chr14:33,907,645...33,923,649
Ensembl chr14:33,907,645...33,923,610

G

glutathione peroxidase 1

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of GPX1 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GPX1 mRNA

PMID:28013214 PMID:37021957

NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542

G

GRAM domain containing 1B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GRAMD1B mRNA

NCBI chr 9:40,204,529...40,443,656
Ensembl chr 9:40,204,529...40,442,679

G

gremlin 2, DAN family BMP antagonist

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GREM2 mRNA

NCBI chr 1:174,661,352...174,749,386
Ensembl chr 1:174,661,351...174,749,385

G

glutathione reductase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of GSR mRNA

NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191

G

glutathione S-transferase, alpha 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of GSTA3 mRNA

NCBI chr 1:21,310,837...21,335,885
Ensembl chr 1:21,310,813...21,335,885

G

H3.3 histone B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of H3F3B mRNA

NCBI chr11:115,912,787...115,921,313
Ensembl chr11:115,912,738...115,918,788

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HADHA mRNA

NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HADHB mRNA

NCBI chr 5:30,360,251...30,389,591
Ensembl chr 5:30,360,246...30,389,591

G

hyaluronan synthase 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HAS2 mRNA

NCBI chr15:56,529,023...56,557,942
Ensembl chr15:56,529,023...56,557,935

G

hemolytic complement

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of C5 protein

NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450

G

hemopoietic cell kinase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HCK mRNA

NCBI chr 2:152,950,388...152,993,361
Ensembl chr 2:152,950,388...152,993,361

G

high mobility group box 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HMGB2 mRNA

NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033

G

3-hydroxy-3-methylglutaryl-Coenzyme A reductase

decreases expression

diisobutyl phthalate results in decreased expression of HMGCR mRNA

PMID:28655647 PMID:33983380

NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444

G

3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1

decreases expression
multiple interactions

diisobutyl phthalate results in decreased expression of HMGCS1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HMGCS1 mRNA

PMID:28655647 PMID:33983380 PMID:39150890

NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796

G

homeobox B8

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXB8 mRNA

NCBI chr11:96,170,227...96,176,151
Ensembl chr11:96,172,731...96,176,141

G

homeobox D3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HOXD3 mRNA

NCBI chr 2:74,542,337...74,578,615
Ensembl chr 2:74,542,271...74,578,786

G

haptoglobin

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of HP mRNA

NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804

G

hydroxysteroid (17-beta) dehydrogenase 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD17B11 mRNA

NCBI chr 5:104,137,631...104,169,662
Ensembl chr 5:104,137,628...104,169,785

G

hydroxysteroid (17-beta) dehydrogenase 3

increases expression

diisobutyl phthalate results in increased expression of HSD17B3 mRNA

NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSD3B1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of HSD3B1 mRNA

PMID:28013214 PMID:35762964

NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3

decreases expression
multiple interactions

diisobutyl phthalate results in decreased expression of HSD3B3 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of HSD3B3 mRNA

NCBI chr 3:98,648,792...98,672,465
Ensembl chr 3:98,648,839...98,670,443

G

hydroxysteroid dehydrogenase like 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSDL2 mRNA

NCBI chr 4:59,581,515...59,618,694
Ensembl chr 4:59,581,563...59,618,689

G

heat shock protein 12A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA

NCBI chr19:58,784,182...58,932,104
Ensembl chr19:58,784,182...58,932,086

G

heat shock protein 8

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSPB8 mRNA

NCBI chr 5:116,546,550...116,560,923
Ensembl chr 5:116,546,550...116,560,923

G

heat shock protein 1 (chaperonin)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HSPD1 mRNA

NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402

G

HtrA serine peptidase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of HTRA1 mRNA

NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390

G

isocitrate dehydrogenase 3 (NAD+) alpha

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDH3A mRNA

NCBI chr 9:54,493,795...54,511,946
Ensembl chr 9:54,493,618...54,511,945

G

isopentenyl-diphosphate delta isomerase, pseudogene 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDI1-PS1 mRNA

NCBI chr 2:53,584,382...53,586,882
Ensembl chr 2:53,586,133...53,586,816

G

indoleamine 2,3-dioxygenase 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of IDO2 mRNA

NCBI chr 8:25,021,908...25,066,430
Ensembl chr 8:25,021,908...25,066,349

G

immediate early response 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IER2 mRNA

NCBI chr 8:85,387,960...85,389,481
Ensembl chr 8:85,387,960...85,389,483

G

interferon gamma

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of IFNG protein

NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797

G

insulin-like growth factor binding protein 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of IGFBP2 protein

NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633

G

insulin-like growth factor binding protein 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IGFBP5 mRNA

NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043

G

insulin-like growth factor binding protein 6

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of IGFBP6 protein

NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946

G

interferon gamma induced GTPase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IGTP mRNA

NCBI chr11:58,090,382...58,098,418
Ensembl chr11:58,090,382...58,098,417

G

interleukin 13

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] affects the expression of and affects the secretion of IL13 protein

NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529

G

interleukin 1 beta

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of IL1B mRNA

NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059

G

interleukin 6

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of IL6 mRNA]

NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979

G

inhibin alpha

decreases expression

diisobutyl phthalate results in decreased expression of INHA mRNA

NCBI chr 1:75,483,872...75,487,010
Ensembl chr 1:75,483,721...75,487,010

G

inositol polyphosphate 5-phosphatase J

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of INPP5J mRNA

NCBI chr11:3,444,272...3,455,521
Ensembl chr11:3,444,375...3,454,821

G

insulin induced gene 1

decreases expression

diisobutyl phthalate results in decreased expression of INSIG1 mRNA

NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660

G

insulin-like 3

decreases expression
multiple interactions

diisobutyl phthalate results in decreased expression of INSL3 mRNA
[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of INSL3 mRNA; [diisobutyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate] results in decreased expression of INSL3 mRNA

PMID:22112501 PMID:33983380 PMID:37788136

NCBI chr 8:72,141,896...72,143,221
Ensembl chr 8:72,141,858...72,143,219

G

interferon regulatory factor 2 binding protein 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRF2BP2 mRNA

NCBI chr 8:127,315,035...127,320,725
Ensembl chr 8:127,315,035...127,320,725

G

immunity-related GTPase family M member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM1 mRNA

NCBI chr11:48,756,072...48,762,247
Ensembl chr11:48,752,795...48,762,510

G

immunity-related GTPase family M member 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGM2 mRNA

NCBI chr11:58,105,803...58,113,609
Ensembl chr11:58,090,444...58,113,608

G

immunity-related GTPase family, Q

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IRGQ mRNA

NCBI chr 7:24,230,073...24,238,025
Ensembl chr 7:24,230,114...24,238,025

G

ISG15 ubiquitin-like modifier

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ISG15 mRNA

NCBI chr 4:156,283,881...156,285,275
Ensembl chr 4:156,283,912...156,285,253

G

integrin alpha 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA11 mRNA

NCBI chr 9:62,585,137...62,691,618
Ensembl chr 9:62,585,108...62,691,264

G

integrin alpha 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA2 mRNA

NCBI chr13:114,969,617...115,068,588
Ensembl chr13:114,969,617...115,068,636

G

integrin alpha 7

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGA7 mRNA

NCBI chr10:128,769,633...128,794,155
Ensembl chr10:128,769,645...128,794,155

G

integrin beta 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITGB3 mRNA

NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302

G

inter-alpha-trypsin inhibitor, heavy chain 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITIH5 mRNA

NCBI chr 2:10,158,354...10,261,340
Ensembl chr 2:10,158,382...10,261,340

G

inositol 1,4,5-triphosphate receptor interacting protein

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ITPRIP mRNA

NCBI chr19:47,883,029...47,907,738
Ensembl chr19:47,883,041...47,907,738

G

jagged 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of JAG1 mRNA

NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564

G

jun B proto-oncogene

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of JUNB mRNA

NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347

G

KN motif and ankyrin repeat domains 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KANK4 mRNA

NCBI chr 4:98,643,129...98,706,295
Ensembl chr 4:98,643,135...98,705,774

G

kelch repeat and BTB (POZ) domain containing 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KBTBD11 mRNA

NCBI chr 8:15,059,408...15,083,333
Ensembl chr 8:15,061,025...15,083,333

G

potassium channel tetramerisation domain containing 10

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KCTD10 mRNA

NCBI chr 5:114,501,633...114,518,566
Ensembl chr 5:114,501,628...114,518,569

G

potassium channel tetramerisation domain containing 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KCTD11 mRNA

NCBI chr11:69,769,090...69,771,811
Ensembl chr11:69,769,087...69,772,232

G

KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KDELR3 mRNA

NCBI chr15:79,400,609...79,411,940
Ensembl chr15:79,400,612...79,411,940

G

kinesin family member 5A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5A protein; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5A mRNA

NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217

G

kinesin family member 5C

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of KIF5C mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KIF5C mRNA

PMID:31199487 PMID:39150890

NCBI chr 2:49,509,298...49,664,790
Ensembl chr 2:49,509,310...49,664,790

G

Kruppel-like transcription factor 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KLF11 mRNA

NCBI chr12:24,701,370...24,712,781
Ensembl chr12:24,701,273...24,712,788

G

lysine methyltransferase 5A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KMT5A mRNA

NCBI chr 5:124,577,980...124,600,371
Ensembl chr 5:124,577,993...124,600,371

G

keratin 18

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of KRT18 mRNA

NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462

G

L1 cell adhesion molecule

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of L1CAM mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of L1CAM protein

PMID:31199487 PMID:37690569

NCBI chr X:72,897,384...72,924,843
Ensembl chr X:72,897,384...72,939,711

G

lysosomal-associated protein transmembrane 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LAPTM5 mRNA

NCBI chr 4:130,640,627...130,663,459
Ensembl chr 4:130,640,436...130,663,452

G

large tumor suppressor 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA

NCBI chr14:57,927,119...57,983,669
Ensembl chr14:57,927,119...57,995,845
Ensembl chr14:57,927,119...57,995,845

G

lipocalin 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LCN2 protein

PMID:31199487 PMID:38954831

NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264

G

low density lipoprotein receptor

decreases expression

diisobutyl phthalate results in decreased expression of LDLR mRNA

NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215

G

leptin

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of LEP protein

NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876

G

leucine-rich repeat-containing G protein-coupled receptor 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LGR4 mRNA

NCBI chr 2:109,747,919...109,844,602
Ensembl chr 2:109,747,992...109,844,602

G

leucine-rich repeat-containing G protein-coupled receptor 6

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LGR6 mRNA

NCBI chr 1:134,911,038...135,033,112
Ensembl chr 1:134,911,039...135,033,014

G

luteinizing hormone beta

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate] results in decreased secretion of LHB protein

NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321

G

luteinizing hormone/choriogonadotropin receptor

multiple interactions

[diethyl phthalate co-treated with diisobutyl phthalate] results in decreased expression of LHCGR mRNA

NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418

G

lipase, hormone sensitive

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LIPE mRNA

NCBI chr 7:25,078,952...25,097,911
Ensembl chr 7:25,078,952...25,098,135

G

LON peptidase N-terminal domain and ring finger 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LONRF2 mRNA

NCBI chr 1:38,832,750...38,875,768
Ensembl chr 1:38,832,726...38,875,792

G

lysophosphatidylcholine acyltransferase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPCAT1 mRNA

NCBI chr13:73,615,332...73,664,539
Ensembl chr13:73,615,316...73,664,541

G

lipin 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPIN1 mRNA

NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967

G

lipoprotein lipase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of LPL mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LPL mRNA

PMID:30768133 PMID:39150890

NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100

G

LRAT domain containing 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRATD1 mRNA

NCBI chr12:14,197,599...14,202,039
Ensembl chr12:14,196,831...14,202,055

G

leucine-rich alpha-2-glycoprotein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRG1 mRNA

NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001

G

leucine rich repeat containing 4B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LRRC4B mRNA

NCBI chr 7:44,091,911...44,112,775
Ensembl chr 7:44,078,442...44,112,775

G

leucine-rich repeats and transmembrane domains 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LRTM2 mRNA

NCBI chr 6:119,292,094...119,315,009
Ensembl chr 6:119,292,094...119,307,727

G

Ly6/neurotoxin 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LYNX1 mRNA

NCBI chr15:74,619,705...74,624,828
Ensembl chr15:74,619,701...74,624,895

G

v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAFK mRNA

NCBI chr 5:139,777,291...139,788,409
Ensembl chr 5:139,777,268...139,788,408

G

MAGE family member E1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAGEE1 mRNA

NCBI chr X:104,163,984...104,167,567
Ensembl chr X:104,163,984...104,167,533

G

microtubule-associated protein 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAP2 mRNA

NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742

G

microtubule-associated protein 6

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAP6 mRNA

NCBI chr 7:98,916,270...98,986,344
Ensembl chr 7:98,916,654...98,986,344

G

microtubule-associated protein, RP/EB family, member 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MAPRE3 mRNA

NCBI chr 5:30,972,075...31,023,447
Ensembl chr 5:30,971,985...31,023,450

G

microtubule-associated protein tau

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MAPT mRNA

NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916

G

membrane bound O-acyltransferase domain containing 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MBOAT1 mRNA

NCBI chr13:30,320,499...30,430,677
Ensembl chr13:30,320,472...30,430,700

G

membrane bound O-acyltransferase domain containing 7

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MBOAT7 mRNA

NCBI chr 7:3,680,788...3,696,188
Ensembl chr 7:3,680,788...3,696,522

G

methylcrotonoyl-Coenzyme A carboxylase 1 (alpha)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MCCC1 mRNA

NCBI chr 3:36,009,584...36,054,843
Ensembl chr 3:36,013,461...36,054,827

G

malic enzyme 3, NADP(+)-dependent, mitochondrial

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ME3 mRNA

NCBI chr 7:89,281,492...89,503,423
Ensembl chr 7:89,281,600...89,503,567

G

mex3 RNA binding family member B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MEX3B mRNA

NCBI chr 7:82,516,541...82,520,784
Ensembl chr 7:82,516,541...82,520,723

G

major facilitator superfamily domain containing 4A

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MFSD4A mRNA

NCBI chr 1:131,947,543...131,997,400
Ensembl chr 1:131,950,544...131,995,800

G

monoglyceride lipase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MGLL mRNA

NCBI chr 6:88,701,397...88,805,342
Ensembl chr 6:88,701,394...88,805,342

G

microsomal glutathione S-transferase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MGST1 mRNA

NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753

G

microRNA 141

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR141

NCBI chr 6:124,694,877...124,694,948
Ensembl chr 6:124,694,877...124,694,948

G

microRNA 184

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MIR184 mRNA

PMID:31199487 PMID:35762964

NCBI chr 9:89,684,313...89,684,381
Ensembl chr 9:89,684,313...89,684,381

G

myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of MLLT11 mRNA

NCBI chr 3:95,125,852...95,139,486
Ensembl chr 3:95,126,446...95,139,482

G

MLX interacting protein-like

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MLXIPL mRNA

NCBI chr 5:135,118,744...135,168,622
Ensembl chr 5:135,118,744...135,167,236

G

membrane metallo endopeptidase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MME mRNA

NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451

G

matrix metallopeptidase 14 (membrane-inserted)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP14 mRNA]

NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821

G

matrix metallopeptidase 16

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] promotes the reaction [CGA protein results in increased expression of MMP16 mRNA]

NCBI chr 4:17,853,072...18,117,479
Ensembl chr 4:17,852,893...18,119,145

G

matrix metallopeptidase 9

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the reaction [CGA protein results in increased expression of MMP9 mRNA]

NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770

G

membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MPP2 mRNA

NCBI chr11:101,947,841...101,979,464
Ensembl chr11:101,947,841...101,979,341

G

myelin protein zero-like 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MPZL2 mRNA

NCBI chr 9:44,951,595...44,965,341
Ensembl chr 9:44,951,097...44,965,313

G

MRG/MORF4L binding protein

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MRGBP mRNA

NCBI chr 2:180,222,990...180,228,097
Ensembl chr 2:180,223,097...180,228,097

G

mitochondrial ribosomal protein L1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MRPL1 mRNA

NCBI chr 5:96,357,357...96,414,586
Ensembl chr 5:96,357,352...96,414,586

G

MTSS I-BAR domain containing 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MTSS2 mRNA

NCBI chr 8:111,447,718...111,468,032
Ensembl chr 8:111,448,108...111,468,032

G

mitochondrial tumor suppressor 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MTUS1 mRNA

NCBI chr 8:41,443,949...41,587,318
Ensembl chr 8:41,443,951...41,586,763

G

mevalonate (diphospho) decarboxylase

decreases expression

diisobutyl phthalate results in decreased expression of MVD mRNA

NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161

G

myosin X

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of MYO10 mRNA

NCBI chr15:25,622,636...25,813,759
Ensembl chr15:25,622,611...25,813,759

G

Ngfi-A binding protein 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NAB2 mRNA

NCBI chr10:127,496,787...127,502,572
Ensembl chr10:127,496,787...127,504,437

G

NAC alpha domain containing

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NACAD mRNA

NCBI chr11:6,547,814...6,556,059
Ensembl chr11:6,547,823...6,556,053

G

NLR family, apoptosis inhibitory protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NAIP1 mRNA

NCBI chr13:100,544,272...100,589,372
Ensembl chr13:100,544,272...100,589,377

G

neurocalcin delta

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NCALD mRNA

NCBI chr15:37,366,419...37,792,816
Ensembl chr15:37,366,419...37,792,814

G

neutral cholesterol ester hydrolase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NCEH1 mRNA

NCBI chr 3:27,237,153...27,299,112
Ensembl chr 3:27,237,114...27,338,757

G

neuronal calcium sensor 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NCS1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NCS1 mRNA

PMID:31199487 PMID:39150890

NCBI chr 2:31,135,766...31,186,001
Ensembl chr 2:31,135,835...31,186,001

G

necdin, MAGE family member

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NDN mRNA

NCBI chr 7:61,998,025...61,999,676
Ensembl chr 7:61,996,317...62,000,010

G

N-myc downstream regulated gene 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NDRG4 mRNA

NCBI chr 8:96,403,602...96,441,584
Ensembl chr 8:96,403,608...96,441,747

G

NADH:ubiquinone oxidoreductase core subunit S1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NDUFS1 mRNA

NCBI chr 1:63,182,751...63,215,981
Ensembl chr 1:63,182,755...63,215,992

G

neurofilament, heavy polypeptide

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFH mRNA

NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064

G

neurofilament, light polypeptide

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NEFL mRNA

NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544

G

NEL-like 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NELL1 mRNA

NCBI chr 7:49,625,098...50,513,037
Ensembl chr 7:49,624,612...50,516,356

G

nuclear factor, erythroid derived 2, like 2

multiple interactions

[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of NFE2L2 mRNA; [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NFE2L2 mRNA

PMID:37021957 PMID:39150890

NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985

G

nuclear factor, erythroid derived 2, like 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NFE2L3 mRNA

NCBI chr 6:51,409,649...51,435,752
Ensembl chr 6:51,409,650...51,435,748

G

nerve growth factor receptor (TNFR superfamily, member 16)

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NGFR mRNA

NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561

G

NHERF family PDZ scaffold protein 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC9A3R1 mRNA

NCBI chr11:115,054,138...115,072,009
Ensembl chr11:115,054,167...115,072,007

G

nicotinamide riboside kinase 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NMRK1 mRNA

NCBI chr19:18,609,380...18,629,555
Ensembl chr19:18,609,314...18,629,792

G

neuronatin

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NNAT mRNA

NCBI chr 2:157,401,936...157,404,445
Ensembl chr 2:157,401,998...157,404,442

G

nucleolar protein 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOL4 mRNA

NCBI chr18:22,826,209...23,174,926
Ensembl chr18:22,826,238...23,174,710

G

nitric oxide synthase 2, inducible

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOS2 mRNA

NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080

G

notch 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NOTCH4 mRNA

NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477

G

N-acetylneuraminate pyruvate lyase

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NPL mRNA

NCBI chr 1:153,378,762...153,425,460
Ensembl chr 1:153,378,761...153,425,791

G

nuclear receptor subfamily 0, group B, member 1

decreases expression

diisobutyl phthalate results in decreased expression of NR0B1 mRNA

NCBI chr X:85,235,381...85,239,553
Ensembl chr X:85,235,370...85,239,553

G

nuclear receptor subfamily 1, group H, member 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR1H4 mRNA

NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447

G

nuclear receptor subfamily 1, group I, member 2

increases activity

diisobutyl phthalate results in increased activity of NR1I2 protein alternative form

NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186

G

nuclear receptor subfamily 1, group I, member 3

multiple interactions
affects binding
increases activity

[diisobutyl phthalate co-treated with Androstanols] results in increased activity of NR1I3 protein alternative form
diisobutyl phthalate binds to NR1I3 protein
diisobutyl phthalate results in increased activity of NR1I3 protein alternative form

PMID:21227907 PMID:25938866

NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270

G

nuclear receptor subfamily 4, group A, member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR4A1 mRNA

NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676

G

nuclear receptor subfamily 4, group A, member 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR4A2 mRNA

NCBI chr 2:56,996,845...57,014,152
Ensembl chr 2:56,996,842...57,014,015

G

nuclear receptor subfamily 4, group A, member 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NR4A3 mRNA

NCBI chr 4:48,045,098...48,086,446
Ensembl chr 4:48,045,153...48,086,447

G

nuclear receptor binding protein 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NRBP2 mRNA

NCBI chr15:75,957,364...75,963,539
Ensembl chr15:75,957,367...75,963,476

G

neurexin II

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NRXN2 mRNA

NCBI chr19:6,468,786...6,583,247
Ensembl chr19:6,468,761...6,594,199

G

NAD(P) dependent steroid dehydrogenase-like

decreases expression

diisobutyl phthalate results in decreased expression of NSDHL mRNA

NCBI chr X:71,962,127...72,002,134
Ensembl chr X:71,962,163...72,002,120

G

neuron specific gene family member 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG1 mRNA
[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NSG1 mRNA

PMID:31199487 PMID:39150890

NCBI chr 5:38,294,537...38,317,087
Ensembl chr 5:38,294,536...38,317,251

G

neuron specific gene family member 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of NSG2 mRNA

NCBI chr11:31,949,678...32,009,211
Ensembl chr11:31,950,463...32,009,202

G

netrin 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NTN4 mRNA

NCBI chr10:93,476,911...93,581,834
Ensembl chr10:93,476,543...93,583,069

G

nucleoporin 210

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NUP210 mRNA

NCBI chr 6:90,990,049...91,095,920
Ensembl chr 6:90,990,050...91,093,811

G

nuclear RNA export factor 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of NXF3 mRNA

NCBI chr X:134,972,272...135,040,382
Ensembl chr X:134,972,848...134,986,004

G

olfactomedin 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of OLFM1 mRNA

NCBI chr 2:28,083,105...28,120,748
Ensembl chr 2:28,083,004...28,120,748

G

olfactomedin-like 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OLFML3 mRNA

NCBI chr 3:103,642,710...103,645,317
Ensembl chr 3:103,629,538...103,645,317

G

opioid receptor-like 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OPRL1 mRNA

NCBI chr 2:181,356,585...181,362,778
Ensembl chr 2:181,356,809...181,362,778

G

olfactory receptor family 5 subfamily M member 3B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OR5M3B mRNA

NCBI chr 2:85,850,984...85,875,152
Ensembl chr 2:85,850,977...85,875,515

G

olfactory receptor family 6 subfamily C member 69B

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OR6C69B mRNA

NCBI chr10:129,626,518...129,627,456
Ensembl chr10:129,623,158...129,630,786

G

oxidative stress induced growth inhibitor family member 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA

NCBI chr 4:15,996,354...16,015,266
Ensembl chr 4:15,997,121...16,013,888

G

procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of P4HA2 mRNA

NCBI chr11:53,991,750...54,022,494
Ensembl chr11:53,990,921...54,022,491

G

palmdelphin

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA

NCBI chr 3:116,711,911...116,762,896
Ensembl chr 3:116,711,907...116,762,636

G

3'-phosphoadenosine 5'-phosphosulfate synthase 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PAPSS2 mRNA

NCBI chr19:32,573,072...32,644,587
Ensembl chr19:32,573,190...32,644,587

G

propionyl-Coenzyme A carboxylase, alpha polypeptide

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCCA mRNA

NCBI chr14:122,721,822...123,127,372
Ensembl chr14:122,771,736...123,128,512

G

protocadherin gamma subfamily A, 11

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCDHGA11 mRNA

NCBI chr18:37,888,826...37,974,926
Ensembl chr18:37,888,784...37,974,926

G

Purkinje cell protein 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of PCP4 mRNA

NCBI chr16:96,268,806...96,326,993
Ensembl chr16:96,268,806...96,326,993

G

proprotein convertase subtilisin/kexin type 1 inhibitor

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCSK1N mRNA

NCBI chr X:7,786,061...7,790,649
Ensembl chr X:7,786,061...7,790,649

G

proprotein convertase subtilisin/kexin type 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCSK2 mRNA

NCBI chr 2:143,388,053...143,658,204
Ensembl chr 2:143,388,076...143,658,205

G

proprotein convertase subtilisin/kexin type 5

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCSK5 mRNA

NCBI chr19:17,409,678...17,815,076
Ensembl chr19:17,409,683...17,814,996

G

proprotein convertase subtilisin/kexin type 9

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in decreased secretion of PCSK9 protein

NCBI chr 4:106,299,531...106,321,522
Ensembl chr 4:106,299,526...106,321,526

G

phosphate cytidylyltransferase 1, choline, alpha isoform

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PCYT1A mRNA

NCBI chr16:32,249,739...32,293,883
Ensembl chr16:32,249,739...32,293,888

G

phosphodiesterase 1B, Ca2+-calmodulin dependent

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE1B mRNA

NCBI chr15:103,411,461...103,438,483
Ensembl chr15:103,411,461...103,438,479

G

phosphodiesterase 3A, cGMP inhibited

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE3A mRNA

NCBI chr 6:141,194,995...141,452,588
Ensembl chr 6:141,194,995...141,453,174

G

phosphodiesterase 3B, cGMP-inhibited

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE3B mRNA

NCBI chr 7:114,014,388...114,137,173
Ensembl chr 7:114,014,516...114,138,486

G

phosphodiesterase 4B, cAMP specific

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE4B mRNA

NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456

G

phosphodiesterase 4D, cAMP specific

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDE4D mRNA

NCBI chr13:108,790,711...110,092,503
Ensembl chr13:108,586,482...110,089,995

G

platelet derived growth factor, B polypeptide

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate] results in increased secretion of PDGFB protein

NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178

G

platelet-derived growth factor, C polypeptide

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDGFC mRNA

NCBI chr 3:80,943,723...81,121,347
Ensembl chr 3:80,943,723...81,121,347

G

pyruvate dehydrogenase kinase, isoenzyme 4

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of PDK4 mRNA

NCBI chr 6:5,483,351...5,496,278
Ensembl chr 6:5,483,351...5,496,309

G

PDZ domain containing RING finger 3

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA

NCBI chr 6:101,126,568...101,354,858
Ensembl chr 6:101,126,570...101,354,858

G

paternally expressed 13

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEG13 mRNA

NCBI chr15:72,677,451...72,682,173
Ensembl chr15:72,677,449...72,682,173

G

period circadian clock 1

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PER1 mRNA

NCBI chr11:68,985,934...69,000,791
Ensembl chr11:68,986,043...69,000,786

G

peroxisomal biogenesis factor 5-like

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEX5L mRNA

NCBI chr 3:33,002,075...33,197,470
Ensembl chr 3:33,003,557...33,197,396

G

profilin 2

multiple interactions

[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phtha